Lead vaccine candidates developed by Oxford University and Moderna against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo, cou
The report indicates that lead vaccine candidates developed by Oxford University and Moderna against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo, could enter Phase 1 trials as early as July.
It further notes that they say that field trials possible within several months, the head of the Coalition for Epidemic Preparedness Innovations, Richard Hatchett, stated on Tuesday.
Source: myjoyonline.com
